サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1386584

移植用HLAタイピング市場レポート：2030年までの動向、予測、競合分析

HLA Typing for Transplant Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

移植用HLAタイピング市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月12日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

移植用HLAタイピングの動向と予測

移植用HLAタイピングの世界市場は、2024年から2030年までのCAGRが8.2%で、2030年までに推定13億米ドルに達すると予想されます。この市場の主な促進要因は、臓器移植手術件数の増加、移植医療の継続的進歩、自己免疫疾患の有病率の増加です。移植用HLAタイピングの世界市場の将来は、独立したリファレンスラボ、病院および移植センター、研究所および学術機関の各市場におけるビジネスチャンスによって有望視されています。

移植用HLAタイピング市場の洞察

Lucintelは、サンプルの迅速な処理のための高いスループット、多種多様なHLA対立遺伝子を検出する能力、および優れた精度により、分子型がより大きなセグメントであり続けると予測しています。

北米は、強固なヘルスケアインフラの存在、高度な移植診断技術の広範な受け入れ、同地域における主要プレイヤーの存在により、引き続き最大の地域となると思われます。

本レポートでは、以下の11の主要な質問について回答する：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 移植市場向けの世界のHLAタイピング：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
  • 移植市場の世界のHLAタイピングの動向（2018年～2023年）と予測（2024年～2030年）
  • 製品タイプ別の世界の移植用HLAタイピング
    • 試薬・消耗品
    • 機器
    • ソフトウェア・サービス
  • 技術別の世界の移植用HLAタイピング
    • 分子アッセイ技術
    • 非分子アッセイ技術
  • 用途別の世界の移植用HLAタイピング
    • 診断
    • 研究
    • その他
  • 最終用途産業別の世界の移植用HLAタイピング
    • 独立リファレンスラボ
    • 病院・移植センター
    • 研究・学術機関
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界の移植用HLAタイピング
  • 北米の移植用HLAタイピング
  • 欧州の移植用HLAタイピング
  • アジア太平洋の移植用HLAタイピング
  • その他地域の移植用HLAタイピング

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 製品タイプ別の世界の移植用HLAタイピング市場の成長機会
    • 技術別の世界の移植用HLAタイピング市場の成長機会
    • 用途別の世界の移植用HLAタイピング市場の成長機会
    • 最終用途産業別の世界の移植用HLAタイピング市場の成長機会
    • 地域別の世界の移植用HLAタイピング市場の成長機会
  • 世界の移植市場向けHLAタイピングの新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の移植用HLAタイピング市場の能力拡大
    • 世界の移植用HLAタイピング市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Qiagen
  • Omixon
  • GenDx
  • Illumina
  • TBG Diagnostics
  • Dickinson
  • Takara Bio
  • F. Hoffman-La Roche
目次

HLA Typing for Transplant Trends and Forecast

The future of the global HLA typing for transplant market looks promising with opportunities in the independent reference laboratory, hospital and transplant centre, and research laboratory & academic institute markets. The global HLA typing for transplant market is expected to reach an estimated $1.3 billion by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising number of organ transplant procedures, continuous advancements in transplant medicine, and increasing prevalence of autoimmune diseases.

A more than 150-page report is developed to help in your business decisions.

HLA Typing for Transplant by Segment

The study includes a forecast for the global HLA typing for transplant by product type, technology, application, end use industry, and region.

HLA Typing for Transplant Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents and Consumables
  • Instruments
  • Software and Services

HLA Typing for Transplant Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Molecular Assay Technologies
  • Non- Molecular Assay Technologies

HLA Typing for Transplant Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic
  • Research
  • Others

HLA Typing for Transplant Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

  • Independent Reference Laboratories
  • Hospitals and Transplant Centres
  • Research Laboratories and Academic Institutes
  • Others

HLA Typing for Transplant Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of HLA Typing for Transplant Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HLA typing for transplant companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HLA typing for transplant companies profiled in this report include-

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Qiagen
  • Omixon
  • GenDx
  • Illumina
  • TBG Diagnostics
  • Dickinson
  • Takara Bio
  • F. Hoffman-La Roche

HLA Typing for Transplant Market Insights

Lucintel forecasts that molecular will remain the larger segment due to its high throughput for the quick processing of samples, ability to detect wide variety of HLA alleles, and excellent accuracy.

North America will remain the largest region due to existence of robust healthcare infrastructure, widespread acceptance of advanced transplant diagnostic technologies, and presence of key players in the region.

Features of the Global HLA Typing for Transplant Market

Market Size Estimates: HLA typing for transplant market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HLA typing for transplant market size by various segments, such as by product type, technology, application, end use industry, and region in terms of ($B).

Regional Analysis: HLA typing for transplant market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end use industries, and regions for the HLA typing for transplant market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HLA typing for transplant market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the HLA typing for transplant market size?

Answer: The global HLA typing for transplant market is expected to reach an estimated $1.3 billion by 2030.

Q.2 What is the growth forecast for HLA typing for transplant market?

Answer: The global HLA typing for transplant market is expected to grow with a CAGR of 8.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the HLA typing for transplant market?

Answer: The major drivers for this market are rising number of organ transplant procedures, continuous advancements in transplant medicine, and increasing prevalence of autoimmune diseases.

Q4. What are the major segments for HLA typing for transplant market?

Answer: The future of the HLA typing for transplant market looks promising with opportunities in the independent reference laboratory, hospital and transplant centre, and research laboratory & academic institute markets.

Q5. Who are the key HLA typing for transplant market companies?

Answer: Some of the key HLA typing for transplant companies are as follows:

  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Qiagen
  • Omixon
  • GenDx
  • Illumina
  • TBG Diagnostics
  • Dickinson
  • Takara Bio
  • F. Hoffman-La Roche

Q6. Which HLA typing for transplant market segment will be the largest in future?

Answer: Lucintel forecasts that molecular will remain the larger segment due to its high throughput for the quick processing of samples, ability to detect wide variety of HLA alleles, and excellent accuracy.

Q7. In HLA typing for transplant market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure, widespread acceptance of advanced transplant diagnostic technologies, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the HLA typing for transplant market by product type (reagents and consumables, instruments, and software and services), technology (molecular assay technologies and non- molecular assay technologies), application (diagnostic, research, and others), end use industry (independent reference laboratories, hospitals and transplant centres, research laboratories and academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HLA Typing for Transplant Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global HLA Typing for Transplant Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global HLA Typing for Transplant Market by Product Type
    • 3.3.1: Reagents and Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software and Services
  • 3.4: Global HLA Typing for Transplant Market by Technology
    • 3.4.1: Molecular Assay Technologies
    • 3.4.2: Non- Molecular Assay Technologies
  • 3.5: Global HLA Typing for Transplant Market by Application
    • 3.5.1: Diagnostic
    • 3.5.2: Research
    • 3.5.3: Others
  • 3.6: Global HLA Typing for Transplant Market by End Use Industry
    • 3.6.1: Independent Reference Laboratories
    • 3.6.2: Hospitals and Transplant Centres
    • 3.6.3: Research Laboratories and Academic Institutes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global HLA Typing for Transplant Market by Region
  • 4.2: North American HLA Typing for Transplant Market
    • 4.2.1: North American HLA Typing for Transplant Market by Technology: Molecular Assay Technologies and Non- Molecular Assay Technologies
    • 4.2.2: North American HLA Typing for Transplant Market by End Use Industry: Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes, and Others
  • 4.3: European HLA Typing for Transplant Market
    • 4.3.1: European HLA Typing for Transplant Market by Technology: Molecular Assay Technologies and Non- Molecular Assay Technologies
    • 4.3.2: European HLA Typing for Transplant Market by End Use Industry: Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes, and Others
  • 4.4: APAC HLA Typing for Transplant Market
    • 4.4.1: APAC HLA Typing for Transplant Market by Technology: Molecular Assay Technologies and Non- Molecular Assay Technologies
    • 4.4.2: APAC HLA Typing for Transplant Market by End Use Industry: Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes, and Others
  • 4.5: ROW HLA Typing for Transplant Market
    • 4.5.1: ROW HLA Typing for Transplant Market by Technology: Molecular Assay Technologies and Non- Molecular Assay Technologies
    • 4.5.2: ROW HLA Typing for Transplant Market by End Use Industry: Independent Reference Laboratories, Hospitals and Transplant Centres, Research Laboratories and Academic Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global HLA Typing for Transplant Market by Product Type
    • 6.1.2: Growth Opportunities for the Global HLA Typing for Transplant Market by Technology
    • 6.1.3: Growth Opportunities for the Global HLA Typing for Transplant Market by Application
    • 6.1.4: Growth Opportunities for the Global HLA Typing for Transplant Market by End Use Industry
    • 6.1.5: Growth Opportunities for the Global HLA Typing for Transplant Market by Region
  • 6.2: Emerging Trends in the Global HLA Typing for Transplant Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global HLA Typing for Transplant Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HLA Typing for Transplant Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Bio-Rad Laboratories
  • 7.3: Qiagen
  • 7.4: Omixon
  • 7.5: GenDx
  • 7.6: Illumina
  • 7.7: TBG Diagnostics
  • 7.8: Dickinson
  • 7.9: Takara Bio
  • 7.10: F. Hoffman-La Roche